Brain implant centre gets £6m funding to grow
BBCThe UK's first centre dedicated to advancing pioneering brain implant technology has secured more than £6m to expand treatments.
The National Centre for Neurotechnology and Neurorestoration (NCNN) in Newcastle uses brain and nervous system technologies to help treat patients with conditions including Parkinson's disease, paralysis and severe pain.
Director Akbar Hussain said it had already delivered "some amazing successes", while scientist Dr Luke Bashford said the investment would allow the centre to "scale up" their work.
The Advanced Research and Invention Agency (ARIA) has paid £3.1m in funding, matched by Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.
Established in 2025, the centre is described by the NHS as the first in the UK dedicated to accelerating the use of technologies that interact directly with the brain and nervous system.
The technology aims to improve the lives of people with conditions including Parkinson's disease, epilepsy, motor neurone disease and spinal cord injuries, as well as those experiencing difficulties with memory, thinking and concentration.
Newcastle brain surgeon Hussain and Newcastle University scientist Bashford are leading the project to expand the use of the technology, with the aim of helping many more patients.
Hussain said neurological conditions were the leading cause of disability worldwide and could have a devastating impact on patients.
He said the centre had already seen "some amazing successes" using innovative brain implants to help patients with Parkinson's disease, paralysis and severe pain.

Bashford said the investment would "enable us to scale up this vital work", bringing together patients, researchers and innovators to develop safe and effective treatments for neurological conditions.
He said it would also help strengthen the UK's position as a global leader in the "rapidly growing field".
The funding will help recruit specialist clinical, technical and research staff, as well as expand facilities to develop and deliver new treatments.
Charity Parkinson's UK welcomed the investment, with research communications lead Becky Jones saying it would "create more opportunities for people to take part in clinical trials or benefit from advanced technologies".
Newcastle Hospitals said international partnerships would also allow larger clinical studies to take place.
Dr Jacques Carolan, programme director at public body ARIA, said there was an extraordinary amount of innovation in neurotechnology.
"The hard part is not simply inventing a new device - it is working out how to get it to the people who need it most.
"NCNN gives us a real-world place to do that."
Follow BBC Newcastle on X, Facebook, Nextdoor and Instagram and listen to Radio Newcastle on BBC Sounds.
